PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 176 filers reported holding PDL BIOPHARMA INC in Q1 2018. The put-call ratio across all filers is 1.67 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,585,000 | +15.1% | 820,500 | +6.4% | 1.49% | +4.7% |
| Q2 2020 | $2,245,000 | -8.6% | 771,500 | -11.5% | 1.43% | -25.0% |
| Q1 2020 | $2,457,000 | -38.7% | 871,300 | -37.0% | 1.90% | -5.8% |
| Q4 2018 | $4,011,000 | +4.1% | 1,383,100 | -5.6% | 2.02% | +29.3% |
| Q3 2018 | $3,853,000 | +3.9% | 1,465,000 | -7.6% | 1.56% | +15.2% |
| Q2 2018 | $3,710,000 | -22.8% | 1,585,500 | -3.0% | 1.36% | -25.2% |
| Q1 2018 | $4,804,000 | +3.8% | 1,634,000 | -3.3% | 1.81% | +12.3% |
| Q4 2017 | $4,630,000 | -21.3% | 1,689,800 | -2.6% | 1.61% | -22.5% |
| Q3 2017 | $5,883,000 | +37.0% | 1,735,500 | -0.2% | 2.08% | +31.0% |
| Q2 2017 | $4,293,000 | – | 1,738,200 | – | 1.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 2,632,000 | $8,817,000 | 2.83% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 551,804 | $1,848,543,000 | 1.54% |
| Nine Chapters Capital Management LLC | 24,300 | $81,000 | 0.57% |
| GREAT POINT PARTNERS LLC | 645,000 | $2,161,000 | 0.55% |
| Virtus ETF Advisers LLC | 198,901 | $666,000 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 1,521,224 | $5,096,000 | 0.27% |
| Amici Capital, LLC | 200,000 | $670,000 | 0.18% |
| Acrospire Investment Management LLC | 70,622 | $237,000 | 0.16% |
| RBF Capital, LLC | 273,976 | $918,000 | 0.16% |
| SECOR Capital Advisors, LP | 383,971 | $1,286,000 | 0.14% |